Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.53M | 5.75M | 12.13M | 11.84M | 13.16M | 11.58M |
Gross Profit | -6.24M | -5.60M | -1.75M | 1.48M | 2.45M | 1.93M |
EBITDA | -36.77M | -39.65M | -45.42M | -39.89M | -37.59M | -14.92M |
Net Income | -39.18M | -73.54M | -50.15M | -39.30M | -40.64M | -18.03M |
Balance Sheet | ||||||
Total Assets | 36.90M | 39.41M | 86.15M | 132.31M | 148.47M | 52.47M |
Cash, Cash Equivalents and Short-Term Investments | 17.45M | 18.19M | 26.56M | 72.56M | 120.20M | 36.07M |
Total Debt | 224.65K | 494.24K | 301.19K | 956.16K | 1.12M | 1.52M |
Total Liabilities | 3.04M | 2.11M | 5.35M | 15.58M | 4.74M | 4.17M |
Stockholders Equity | 33.86M | 37.29M | 80.79M | 116.73M | 143.73M | 48.30M |
Cash Flow | ||||||
Free Cash Flow | -19.81M | -26.66M | -42.86M | -43.39M | -31.83M | -15.45M |
Operating Cash Flow | -17.54M | -23.74M | -26.28M | -24.52M | -26.98M | -13.96M |
Investing Cash Flow | -2.32M | -2.92M | -19.28M | -21.17M | -4.85M | -1.49M |
Financing Cash Flow | 27.43M | 18.29M | -449.56K | -1.95M | 115.97M | 40.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | 297.89M | 16.48 | 17.08% | ― | 24.09% | 0.00% | |
61 Neutral | 371.50M | -3.65 | -110.84% | ― | -19.83% | 73.22% | |
54 Neutral | 684.49M | -9.61 | -30.10% | ― | -18.94% | -197.82% | |
48 Neutral | $183.30M | ― | -113.13% | ― | -12.75% | 57.64% | |
44 Neutral | 30.06M | -0.60 | -204.12% | ― | -9.05% | 77.41% | |
44 Neutral | 8.41M | -4.42 | 0.00% | ― | 11.95% | -956.47% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
On September 3, 2025, Vuzix Corporation announced the appointment of Chris Parkinson, PhD., as the president of its Enterprise Solutions business unit. Dr. Parkinson’s compensation package includes a base salary, participation in bonus and equity incentive plans, and stock awards contingent on achieving specific financial targets by 2028, indicating a strategic focus on enhancing the unit’s performance and aligning leadership incentives with company growth objectives.
The most recent analyst rating on (VUZI) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Vuzix stock, see the VUZI Stock Forecast page.
On August 5, 2025, Alasdair MacKinnon was elected to the board of directors of Vuzix Corporation, where he will also serve on the nominating, audit (as Chairperson), and compensation committees. This appointment follows the passing of Edward Kay, a board member since April 2016, on July 23, 2025.
The most recent analyst rating on (VUZI) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Vuzix stock, see the VUZI Stock Forecast page.